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Background: Diffusion-weighted (DW) imaging has shown potential to differentiate between malignant and
benign breast lesions. However, different b values have been used with varied sensitivity and specificity. This study
aims to prospectively evaluate the influence of b value on the detection and assessment of breast lesions.
Methods: Institutional review board approval and informed patient consent were obtained. Between February 2010
and September 2010, sixty women suspected of having breast cancer by clinical examination and mammography
underwent bilateral breast MRI and DW imaging (with maximum b values of 600, 800, and 1000 s/mm2).
Conspicuity grades of lesions at different b values on DW images were performed. Signal intensity and apparent
diffusion coefficient (ADC) values were recorded and compared among different b values by the signal-to-noise
ratio (SNR), contrast-to-noise ratio (CNR) and receiver operating characteristic (ROC) curve.
Results: Fifty-seven lesions from 52 recruited patients including 39/57 (68%) malignant and 18/57 (32%) benign
were confirmed with pathology. DCE MRI accurately detected 53 lesions with the sensitivity of 93.0% and specificity
of 66.7%, and DW imaging accurately detected 51 lesions with the sensitivity of 89.5% and specificity of 100%.
There were no significant differences in conspicuity grades compared among the three b values (P= 0.072),
although the SNR and CNR of breast lesions decreased significantly with higher b values. Mean ADCs of malignant
lesions (b = 600 s/mm2, 1.07 ± 0.26 × 10-3 mm2/s; b = 800 s/mm2, 0.96 ± 0.22 × 10-3 mm2/s; b = 1000 s/mm2,
0.92 ± 0.26 × 10-3 mm2/s) were significantly lower than those of benign lesions (b = 600 s/mm2,
1.55 ± 0.40 × 10-3 mm2/s; b = 800 s/mm2, 1.43 ± 0.38 × 10-3 mm2/s; b = 1000 s/mm2, 1.49 ± 0.38 × 10-3 mm2/s)
with all P values <0.001, but there were no significant differences among the three b values (P= 0.303 and
0.840 for malignant and benign lesions, respectively). According to the area under the ROC curves, which
were derived from ADC and differentiate malignant from benign lesions, no significant differences were
found among the three b values (P= 0.743).
Conclusions: DW imaging is a potential adjunct to conventional MRI in the differentiation between
malignant and benign breast lesions. Varying the maximum b value from 600 to 1000 s/mm2 does not
influence the conspicuity of breast lesions on DW imaging at 1.5 T.Background
Magnetic resonance imaging (MRI) is becoming a
powerful tool to help with the detection, diagnosis, and
staging of breast cancer [1-3]. Based on the morphology
and enhancement pattern of lesions, contrast-enhanced
MRI offers an overall sensitivity of 90% and specificity of
72% in detecting breast lesions according to a published
meta-analysis [2]. Therefore the classification of a breast* Correspondence: xijing_h@vip.tom.com
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reproduction in any medium, provided the orlesion as malignant or benign still has its shortcomings
when detected with MRI [2,4].
In recent years, diffusion-weighted (DW) imaging has
been applied to distinguish between malignant and be-
nign breast lesions [5-11]. DW imaging allows for non-
invasive characterization of biologic tissues based on
their water diffusion properties. Additionally, it provides
information about the biophysical properties of tissues,
such as cell organization and density, microstructure,
and microcirculation. DW imaging enables the quantita-
tive evaluation of apparent diffusion coefficient (ADC),
an important parameter since a lower ADC has beentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of restricted water movement in high cellularity tumours
(5,12). ADC may be an effective parameter in distin-
guishing between malignant and benign breast lesions.
However, sensitivity and specificity values vary and range
from 62.5% to 92.8% and 45.8% to 96.7%, respectively
[13]. The reported mean ADC of malignant lesions
ranges from 0.90 to 1.61 × 10-3 mm2/s and that of benign
lesions from 1.41 to 2.01 × 10-3 mm2/s. These distribu-
tions have resulted in a recommended ADC cutoff value
ranging from 1.1 to 1.6 × 10-3 mm2/s between malignant
and benign lesions [14]. Comparison of the diagnostic
performance of breast DW imaging among the studies
has been compromised by the lack of standardization
[15-17].
On clinical MRI scanners, diffusion sensitivity is easily
altered by changing the diffusion gradient factor, which
is also known as the “b value”. This value is proportional
to the gradient amplitude and duration. By using at least
two different b values, the ADC can be calculated.
Tsushima et al. [14] reported that the maximum b value
(bmax) correlated with the mean ADC of malignant and
benign tumours. In previous studies, it should be noted
that bmax ranged from 300 to 1000 s/mm
2, with a total of
two to five values in between [18]. For DW imaging, a
higher b value provides more tissue diffusivity and less
T2 shine-through effect [19,20]. However, higher b values
may result in poor image quality due to an inferior
signal-to-noise ratio (SNR) at 1.5 T [21,22]. Therefore,
Matsuoka et al. proposed a systematic evaluation of b
values [23]. The optimum b value should sufficiently sup-
press the background signal of the glandular parenchyma
and provide a lesion signal that is strong enough to allow
image interpretation. Additionally, it should differentiate
malignant and benign lesions with the best accuracy.
Based on these concepts we have carried out a pro-
spective study to evaluate the influence of different b
values on lesion conspicuity, the ADC measurement and
the performance of ADC for the differential diagnosis
between malignant and benign breast lesions.
Methods
Patients
The study was approved by our institutional review
board. Informed consent was obtained from all patients
before participation in the study. Sixty patients with
palpable breast mass and clinical indication for breast
MRI were enrolled from February 2010 to September
2010. Three patients were excluded because of move-
ment or susceptibility artifacts seen on DW imaging.
Two additional patients were lost without sufficient
follow-up. Thus, 55 women (mean age, 49.6 years; range,
23-75 years) who met the following inclusion criteria
were included in our study. 1) Insufficient or suspiciousmammography findings (breast mass, architectural
distortion, and focal asymmetry) diagnosed as Breast Im-
aging Reporting and Data System (BI-RADS) 0, 4, 5; 2)
The final diagnosis was confirmed by means of surgery
or core needle biopsy; 3) Clinical and imaging follow-ups
were performed for at least 12 months by using a com-
bination of ultrasound and mammography.
MRI protocol
MRI examination was performed with a 1.5 T system
(Signa; GE Medical Systems, Milwaukee, Wisconsin)
using a dedicated four-channel breast coil on patients in
the prone position. The imaging protocol began with
standard anatomical series, including fast spin-echo
(FSE) T1-weighted imaging, FSE T2-weighted imaging,
and short T1 inversion recovery (STIR) imaging. Subse-
quently, three distinct DW sequences using b = 0 and
b = 600, 800 or 1000 s/mm2 were performed by using
single-shot echo-planar imaging (SSEPI) and frequency
selection fat-suppression with the same following
parameters: TR/TE= 5000/72.1 ms, matrices = 128 × 128,
number of excitations = 4, section thickness/interslice
gap = 5/0 mm, and field of view = 320 mm. The DW
series were acquired in the transverse plane and covered
both breasts. Diffusion gradients were encoded in 3 or-
thogonal axes (x, y, and z). Acquisition time was 1 mi-
nute 20 seconds with 20-24 slices. Finally, a T1-weighted
3D fast spoiled gradient-recalled echo sequence with
parallel imaging (VIBRANT) sequence was used for
dynamic contrast-enhanced imaging. Precontrast T1-
weighted images were subtracted from the postcontrast
T1-weighted dynamic images on a pixel-by-pixel basis.
Image analysis and data acquisition
All images were transferred to a workstation (Advantage
Windows, version 4.2; GE Healthcare) for analysis, and
the DW images were postprocessed with commercial
software (FuncTool, GE Healthcare) to obtain ADC
maps. Each patient had 3 ADC maps created using two
b values, 0 and either 600, 800, or 1000 s/mm2. Two
radiologists (both with 5 years of experience in breast
imaging; 11 and 6 years of experience in MRI, respect-
ively) independently evaluated each DW image and
ADC map alone. To resolve disagreement between
observers, a third radiologist (with 5 years of experience
in breast imaging; 20 years of experience in MRI)
assessed all involved items. The majority opinion was
used for analysis.
Each reviewer graded the conspicuity of lesions on a 5
point confidence scale based on the appearance and sig-
nal strength of lesions on the high b value DW image
(Table 1).
Signal intensity (SI) was recorded on the high b value
DW imaging and ADC was documented. Circular
Table 1 Conspicuity grades of breast lesions on the high
b value DW imaging
Grade Description
1 = not seen Isointensity (symmetric signal intensity
of bilateral breast)
2 = probably seen Nonlocalized, mild to moderate signal
with indistinct margin
3 = seen Circumscribed, mild to moderate signal
with definite margin
4 = readily seen Nonlocalized, strong signal with indistinct margin
5 =well seen Circumscribed, strong signal with definite margin
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central region of the homogeneous lesions, or in the
hypointensity region of the heterogeneous lesions on
ADC maps using narrow window width. Lesion signal
intensity (SIlesion) and ADC were then automatically cal-
culated. Signal intensity (SInormal) and ADC of normal
tissue were measured by placing ROIs in homogeneous
breast parenchyma without enhancement in the centre
of the contralateral breast, avoiding contamination by
fatty tissue. Finally, ROIs were drawn manually in the
anterior area outside of the breast to measure noise in-
tensity (SInoise) and standard deviation (SDnoise). The
area of ROI was measured to be 10 ± 2 mm2.Pathology analysis
The surgeon and study coordinator recorded the lesion
location for all patients who underwent surgery or bi-
opsy. A pathologist then performed pathological examin-
ation blinded to imaging diagnosis. The results of
anatomy and histology were correlated with the results
of MRI by the study coordinator who had access to all
images and clinical data of the patients, including their
pathology.Table 2 Histological composition of malignant and
benign lesions
Malignant (n=39) Benign (n=18)
IDC 33 Hyperplasia 7
Medullary carcinoma 3 Fibroadenoma 4




IDC invasive ductal carcinoma; DCIS ductal carcinoma in situ.Statistical analysis
Data were analyzed using the SPSS13.0 software package
(SPSS Inc, Chicago, IL, USA). Probability values of less
than 0.05 were considered significant. The conspicuity
grades of the lesions on 3 DW series (b = 0, 600), (b = 0,
800), (b = 0, 1000) were compared using a Friedman
signed rank test. SI was analyzed by measurement of
SNR and contrast-to-noise ratio (CNR). SNR was calcu-
lated by SNR= SIlesion/SDnoise. CNR was calculated by
CNR= (SIlesion-SInormal)/SDnoise. Comparisons of the
mean SIlesion, SInormal, SInoise, SNR, CNR, and ADC
among different b values were performed using one-way
analysis of variance (ANOVA) test. For comparison of
the mean ADC between malignant and benign lesions,
we used the independent samples t-test. Receiver operat-
ing characteristic (ROC) curve analysis was used to
quantify the diagnostic accuracy of ADC measurements.Nonparametric testing was performed to compare the
area under the curve (AUC).Results
Lesion detection
Fifty-seven lesions from 52 women were analysed
including 39/57 malignant (mean size, 15 mm; range,
7-45 mm) and 18/57 benign (mean size, 17 mm; range
7-50 mm) –see Table 2 for pathological subtypes.
There were also 3 normal women. Contrast-enhanced
imaging accurately detected 53 lesions and missed 2
hyperplasia, 1 lipoma and 1 fibroma with the sensitiv-
ity of 93.0% (53/57) and specificity of 66.7% (2/3). DW
imaging accurately detected 51 lesions and missed the
same four lesions, 1 other hyperplasia and 1 ductal
carcinoma in situ (DCIS) with the sensitivity of 89.5%
(51/57) and specificity of 100% (3/3). While the fibroma
was not seen on both contrast-enhanced imaging and
DW imaging, it was detected on anatomical imaging.
Typical examples of the early contrast-enhanced subtrac-
tion image, DW image, and ADC map are shown in
Figure 1.Conspicuity on DW imaging
Most malignant lesions were circumscribed and dis-
played strong signals with definite margins, and benign
lesions displayed mild to moderate signal with indistinct
or definite margins on DW images. Mean conspicuity
grades of malignant lesions were 4.44 ± 0.97 at b = 600 s/
mm2, 4.38 ± 1.04 at b = 800 s/mm2 and 4.36 ± 0.96 at
b = 1000 s/mm2. Those of benign lesions were 2.56 ± 1.38
at b = 600 s/mm2, 2.56 ± 1.38 at b = 800 s/mm2 and
2.17 ± 0.99 at b = 1000 s/mm2. There was a high signifi-
cant difference in the conspicuity between malignant and
benign lesions (P < 0.0001). Among 38 malignant lesions
detected by DW imaging, thirty-three (86.8%) lesions
showed same conspicuity grade, 3 (7.9%) darker and 2
(5.3%) brighter with increasing b values. Ten/13 (76.9%)
benign lesions showed same conspicuity grade and 3/13
(23.1%) darker with increasing b values. The conspicuity
grades of breast lesions were not significantly different
Figure 1 MR images of a 49-year-old woman with invasive
ductal carcinoma. MR images of a 49-year-old woman with
invasive ductal carcinoma on (a) early contrast-enhanced subtraction
image, (b) gray-level DW image, and (c) ADC map.
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of five conspicuity grades are shown in Figure 2.
SI on DW imaging
SI on DW imaging depends on the magnitude of the dif-
fusion for all lesions and normal parenchyma (Table 3).
When b values increased from 600 to 1000 s/mm2, the
average SI of malignant lesions, benign lesions, and nor-
mal parenchyma decreased from 853.2 to 473.7 (a de-
crease of 44.5%), 719.4 to 441.4 (38.6% reduced), and
254.2 to 150.1 (41.0% reduced), respectively. However,
SInoise was independent of with the change of b value.
Consequently, the average SNR of malignant and benign
lesions decreased significantly from 133.43 to 71.92 and
117.53 to 69.60 with higher b values, respectively
(P < 0.001 for malignancy and P= 0.012 for benign
lesions). Because the SIlesion of malignant lesions
decreased more quickly than that of benign and SInormal,
the average CNR of malignant lesions decreasedsignificantly with higher b values (P= 0.003). However,
there was no significant decrease for benign lesions
(P= 0.059).
ADC performance
The distribution of ADC for malignant and benign lesions
calculated with different b values is shown in Table 4.
Mean ADCs of malignant lesions (b = 600 s/mm2,
1.07 ± 0.26 × 10-3 mm2/s; b = 800 s/mm2, 0.96 ± 0.22 ×
10-3 mm2/s; b = 1000 s/mm2, 0.92 ± 0.26 × 10-3 mm2/s)
were significantly lower than those of benign lesions
(b = 600 s/mm2, 1.55 ± 0.40 × 10-3 mm2/s; b = 800 s/mm2,
1.43 ± 0.38 × 10-3 mm2/s; b = 1000 s/mm2, 1.49 ± 0.38 ×
10-3 mm2/s) with all P values <0.001. The differences in
ADC calculation among the three b values were not sta-
tistically significant (P= 0.436). Furthermore, analysis of
malignant and benign subgroups did not show significant
differences in ADC calculation among the three b values,
with P values of 0.303 and 0.840, respectively.
ROC curves derived from ADC differentiating malig-
nant from benign lesions are displayed in Figure 3. ROC
analysis revealed AUC of 0.858 ± 0.075 (95% confidence
interval 0.681-0.973) at b = 600 s/mm2, 0.870 ± 0.081
(95% confidence interval 0.672-0.988) at b = 800 s/mm2,
and 0.866 ± 0.073 (95% confidence interval 0.692-0.976)
at b = 1000 s/mm2. No significant difference was found
among the three b values (P= 0.743).
Discussion
DW imaging involves the random motion of water mole-
cules, which is detected as attenuation of the measured
SI [15]. The motion of water molecules is more restricted
in tissues with a higher cellular density and associated
with numerous intact cell membranes [5,12,24]. There-
fore, highly cellular areas will appear to be higher in SI
on DW images. Our study demonstrates that breast
lesions displayed mild to strong SI on DW images com-
pared to surrounding breast parenchyma, and intensity
of malignant lesions was generally higher than that of be-
nign lesions. Mean conspicuity grades of malignant
lesions were 4.44 ± 0.97 at b = 600 s/mm2, 4.38 ± 1.04 at
b = 800 s/mm2 and 4.36 ± 0.96 at b = 1000 s/mm2. Those
of benign lesions were 2.56 ± 1.38 at b = 600 s/mm2,
2.56 ± 1.38 at b = 800 s/mm2 and 2.17 ± 0.99 at
b = 1000 s/mm2. There was a highly significant difference
in the conspicuity between malignant and benign lesions
(P < 0.0001). Most malignant lesions were circumscribed
and displayed strong signals with definite margins on
DW images. Margin characteristics, such as the appear-
ance of being spiculated, could not be displayed on DW
images for inferior spatial resolution and partial-volume
effect. Most benign lesions displayed mild to moderate
signal with indistinct or definite margins on DW images.
However, DW imaging cannot detect all lesions detected
Figure 2 DW images of lesions graded as 1, 2, 3, 4, and 5 point. DW images of lesions graded as 1, 2, 3, 4, and 5 point based on the
appearance and signal strength of lesions compared with surrounding breast parenchyma. (a) Grade 1 with symmetric signal intensity of bilateral
breast. (b) Hyperplasia lesion in left breast scored as 2 with regional distribution, indistinct margin and moderate signal. (c) Fibroadenoma in left
breast (arrow) scored as 3 with circumscribed appearance, definite margin and moderate signal. Another hyperintensity lesion is a cyst, which
was not included in the study. (d) Invasive ductal carcinoma in right breast scored as 4 with segmental distribution, indistinct margin and strong
signal. (e) Invasive ductal carcinoma in right breast scored as 5 with circumscribed appearance, definite margin and strong signal.
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viously, with 6–37.5% of malignant breast lesions report-
edly not visible on DW imaging [25-27]. One DCIS and 1
hyperplastic lesion presented as non-mass enhancement
on contrast-enhanced imaging but were invisible on DW
imaging in the study. One fibroma displayed significant
hypointensity on both T1WI and T2WI, but it was not
detected on DW imaging because the signal intensity
was similar to background.
DW imaging also allows quantitative calculation of
ADC for each pixel of the image and is displayed as a
parametric map. ADC is measured by acquiring the MR
signal at least twice, typically with (Sb) and without (S0)
diffusion weighting by the following formula: ADC=
[In (S0/Sb)]/b, where Sb and S0 are the signal intensities
on the DW imaging and the reference imaging without
diffusion weighting, respectively [28]. Areas of restricted





600 853.2 ± 58.6 719.4 ± 34.4 254.2 ± 89.2
800 629.3 ± 47.5 571.6 ± 28.6 178.4 ± 60.8
1000 473.4 ± 40.3 441.4 ± 21.1 150.1 ± 45.8
SD standard deviation.compared with less cellular areas that return higher
ADC values. Malignant tumours are frequently more
cellular than benign lesions from which they originate
and, thus, appear to be of relatively low ADC levels on
ADC maps. Furthermore, ADC of invasive tumours
appears to be lower than that of carcinoma in situ
[5-7,9,29-31]. High-grade lesions with the highest cell
proliferation rate would have the lowest ADC, which is
still controversial [12,31-33]. Our results are in good
agreement with previously published results on breast
ADC calculation. The mean ADCs of breast cancers were
significantly lower than those of benign lesions with all
P values <0.001 at b values of 600, 800 and 1000 s/mm2.
However, for some malignant and benign lesions, there is
overlap between ADC values. This is based both on our
study and the studies of others. Based on pathological
analysis, 1 invasive ductal carcinoma and 1 medullary
carcinoma showed ADCs that were within theages (Mean±SD)
SNR CNR
Malignant Benign Malignant Benign
133.4 ± 20.4 117.5 ± 7.2 89.7 ± 15.9 77.3 ± 5.9
97.9 ± 6.8 83.7 ± 8.9 64.1 ± 4.8 54.5 ± 8.0
69.6 ± 4.0 59.6 ± 8.9 46.0 ± 3.4 40.3 ± 7.9







95% Confidence interval Mean ADC of
benign lesions
(Mean± SD)
95% Confidence interval P value
Lower bound Upper bound Lower bound Upper bound
1000 0.92 ± 0.26 0.90 1.07 1.49 ± 0.38 1.19 1.65 <0.001
800 1.96 ± 0.22 0.93 1.07 1.43 ± 0.38 1.22 1.68 <0.001
600 1.07 ± 0.26 0.98 1.15 1.55 ± 0.40 1.26 1.75 <0.001
F value 1.206 1.175
P value 0.303 0.840
SD standard deviation.
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cellular density. One plasma cell mastitis showed a very
small ADC value, possibly because of an increase in
macromolecule protein and phlogocyte infiltration.
Therefore, detection and characterization of breast
lesions based solely on DW imaging is not sufficiently ac-
curate, and DW imaging cannot solely substitute for
other MR methods. DW imaging can be a potential ad-
junct to conventional MRI in the differentiation between
malignant and benign lesions for fast imaging without
the use of a contrast agent.
The diffusion gradient factor, also known as the “b
value”, is an important parameter of DW imaging and
determined by the following formula: b = γ2 G2 δ2(Δ –
δ/3), where γ is the magnetogyric ratio, G is the gradient
intensity, δ is the duration of the applied gradient, and Δ
is the time interval between the paired gradients. AFigure 3 ROC curves. Receiver operating characteristic (ROC)
curves derived from ADC in differencing malignant from benign
lesions at three b values. The areas under the curves at b values of
600, 800, 1000 s/mm2 were 0.858, 0.870 and 0.866, respectively.
There is no significant difference among three b values (P= 0.743).greater b value indicates a more severe phase dispersion
of water molecules and a more reduced signal under the
effect of gradient pulse on DW imaging [15]. Our study
demonstrates that the average SIlesion and SInormal
decreased with increasing b values, and SI was more se-
verely reduced in malignant than in benign lesions and
normal parenchyma. Although SNR and CNR of lesions
decreased significantly, the degree was not great enough
to be visually identified on DW imaging with b value in-
creasing from 600 to 1000 s/mm2. Most malignant (33/
38) and benign (10/13) lesions showed the same conspi-
cuity grades on the three DW imaging. All of lesions
detected on the DW imaging at b = 600 s/mm2 remained
at significant level on the DW imaging at the higher b
values although the SI of some lesions decreased with
increasing b values. The conspicuity grades of breast
lesions were not significantly different among the three
b values (P= 0.072). Bogner et al. [18] also compared
CNR of breast lesions at different b values on DW im-
aging. They have found that mean CNR for malignant
and benign tumours rose with increasing b values from
0 to 850 s/mm2, but decreased with even higher b values
from 850 to 1200 s/mm2. The result of our study was
not consistent with that of theirs. There are two consid-
erable differences in materials and methods compared
between our study and their study. First, we performed
DW imaging at 1.5 T and they performed at 3.0 T. Sec-
ond, CNR were calculated differently. We directly mea-
sured SDnoise in the anterior areas outside of breast [34].
They calculated the standard deviation of intensities σlesion
and σtissue in both volumes as SDnoise.
We also found that there were no significant differ-
ences for ADC calculation among the three b values
(P= 0.436). The results are consistent with previously
published data [35]. Conversely, Peters et al. [36] have
found that ADC of breast lesions varied substantially
with the choice of different b values. However, they used
quite different b values at 0, 150, 499, and 1500 s/mm2.
ROC analysis revealed AUC of 0.858 ± 0.075 at b = 600 s/
mm2, 0.870 ± 0.081 at b = 800 s/mm2 and 0.866 ± 0.073
at b = 1000 s/mm2 for the differentiation between malig-
nant and benign lesions. No statistical significances were
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in good with previously published data involving the de-
gree of b values ranged from 150 to 1500 s/mm2 [35,36].
It is first to prospectively evaluate the influence of b
values on both the display and ADC measurement of
breast lesions on DW imaging at 1.5 T. So far, only one
similar study performed using 3.0 T [18]. Our results
suggest that there were significant differences in mor-
phologic pattern and signal strength between malignant
and benign lesions (P < 0.0001). Most malignant lesions
were circumscribed and displayed strong signals with
definite margins on DW images. Most benign lesions
displayed mild to moderate signal with indistinct or def-
inite margins on DW images. Other studies also demon-
strated that strong signal on DW images could be help
to diagnose malignant lesions, which is especially mean-
ingful for patients who can’t accept contrast agent
[37,38]. The ductus or branch distribution and the sign
of ring-shape were only seen on malignant lesions in our
initial study. Many articles have investigated the per-
formance of ADC in discriminating breast lesions. How-
ever, the pooled ADC of malignant and benign lesions
and their diagnostic performance vary with pathophysio-
logic characteristics, MRI techniques, and diagnostic cri-
teria for malignancy in the studies. We think that the
appearance pattern on DW imaging has potential value
for differentiating malignant and benign breast lesions.
This hypothesis should be verified by more clinical
investigations.
Our study has some limitations. First, ROIs to measure
SI and ADC were set by the operators, which is subject-
ive and that little is known about the reproducibility of
measurements. We found that some breast lesions were
heterogeneous on DW images and ADC maps. Most
tumours, especially malignant, have heterogeneous
microenvironments. By drawing an ROI around a
tumour, the summary statistical value does not ad-
equately reflect lesion characteristics [15]. In order to re-
duce the measurement biases and avoid contamination
of the data by adjacent structures, we used a fixed small
size of ROI. We selected the hypointensity region of the
heterogeneous lesions on ADC maps which was the
highest cellular density area on histopathological speci-
mens as ROI to avoid omitting a malignant component
of any given lesion.
In addition, we combined the minimal b value of
0 mm2/s and the maximum b values ranging from 600
to 1000 mm2/s to calculate ADC. According to previ-
ously published articles, the use of multiple b values did
not increase the precision of ADC measurements. In-
stead, it increased vulnerability of patient movement due
to longer acquisition times [35]. A study performed with
a 3.0 T MR imager suggested that ADC determination
and DW imaging quality was optimum with a combinedb value of 50 and 850 s/mm2 [18]. Therefore, further in-
vestigation is needed to estimate whether another mini-
mum b value, other than 0 mm2/s, can reduce the
perfusion effect and T2-shine through effect on DW
imaging.
Conclusions
DW imaging is a potential adjunct to conventional
breast MRI in differentiating between malignant and be-
nign lesions. The performance of DW imaging at 1.5 T
is not significantly influenced by varying the maximum
b value from 600 to 1000 s/mm2. Further studies with
larger populations are needed to confirm the use of DW
imaging in the evaluation of breast lesions.
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